세계의 멀티오믹스 시장 : 제품 및 서비스별, 유형별, 플랫폼별, 용도별, 최종 용도별, 지역별

Global Multiomics Market, By Product & Service, By Type, By Platform, By Application, By End User, By Geography

US $ 4,500 ￦ 6,531,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000 ￦ 10,159,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,514,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

멀티오믹스 세계 시장은 2025년에 24억 7,000만 달러로 추정되며, 2032년에는 67억 3,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 15.4%의 CAGR로 성장할 것으로 예상됩니다.

보고서 범위		보고서 상세
기준 연도	2024년	2025년 시장 규모	24억 7,000만 달러
실적 데이터	2020년부터 2024년까지	예측 기간	2025년부터 2032년까지
예측 기간 : 2025-2032년 CAGR	15.40	2032년 가치 예측	67억 3,000만 달러

멀티오믹스는 유전체학, 후성유전체학, 전사체학, 단백질체학, 대사체학 등 다양한 오믹스 기술을 결합하여 생물학적 시스템에 대한 종합적인 인사이트를 얻는 통합 오믹스 접근법을 말합니다. 멀티오믹스는 여러 생물학적 데이터를 통합함으로써 싱글오믹스 접근법에 비해 분자 메커니즘, 경로, 네트워크에 대한 더 깊은 이해를 용이하게 합니다. 이를 통해 연구자들은 생물학적 과정과 표현형에 대한 보다 완전한 전체 그림을 얻을 수 있습니다. 멀티오믹스 시장은 연구자들이 건강과 질병을 연구하기 위한 통합오믹스 전략의 가능성을 인식함에 따라 급성장하고 있습니다. 실험 기술, 생물정보학 도구, 컴퓨팅 파워의 발전은 생물 의학 연구에서의 멀티오믹스 적용을 더욱 가속화하고 있습니다.

시장 역학:

개인맞춤의료, 신약개발, 시장개척을 위한 멀티오믹스 도입 확대는 향후 수년간 멀티오믹스 시장의 성장을 촉진할 것으로 예상되는 주요 요인 중 일부입니다. 맞춤형 의료에서는 환자의 분자 프로파일을 기반으로 효과적인 맞춤형 치료법을 개발하기 위해 멀티오믹스 접근법을 활용하고 있습니다. 제약사들도 멀티오믹스를 활용하여 새로운 신약 타겟과 바이오마커를 발굴하고 정밀 치료제를 개발하고 있습니다. 그러나 대규모의 복잡한 멀티오믹스 데이터세트가 가져오는 데이터 통합 및 관리의 어려움과 종합적인 분석 도구의 부족은 시장 성장을 저해하는 요인 중 하나입니다. 사용자 친화적인 데이터 분석 솔루션의 개발, 데이터 처리 워크플로우의 표준화, 오믹스 데이터 리포지토리 구축은 예측 기간 동안 멀티오믹스 시장 플레이어에게 유리한 기회를 창출할 수 있습니다.

본 조사의 주요 특징

• 세계의 멀티오믹스(Multiomics) 시장에 대해 조사분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 멀티오믹스 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 멀티오믹스 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 멀티오믹스 세계 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 서비스 제공 포트폴리오
• PEST 분석
• PORTER의 분석
• 인수합병 시나리오
• 파이프라인 분석

제4장 멀티오믹스 세계 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 멀티오믹스 세계 시장, 제품 및 서비스별, 2020-2032년

• 제품
• 기기
• 소모품
• 소프트웨어
• 서비스

제6장 멀티오믹스 세계 시장, 유형별, 2020-2032년

• 단일세포 멀티오믹스
• 벌크 멀티오믹스

제7장 멀티오믹스 세계 시장, 플랫폼별, 2020-2032년

• 유전체학
• 전사체학
• 단백질체학
• 대사체학
• 통합 오믹스 플랫폼

제8장 멀티오믹스 세계 시장, 용도별, 2020-2032년

• 진단
• 의약품 발견과 개발
• 맞춤형 의료
• 농업유전체학
• 기타(환경 모니터링 등)

제9장 멀티오믹스 세계 시장, 최종 용도별, 2020-2032년

• 제약 및 바이오테크놀러지 기업
• 학술조사기관
• 임상 조사기관(CRO)
• 기타(병원·진단 센터 등)

제10장 멀티오믹스 세계 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제11장 경쟁 구도

• BD
• Thermo Fisher Scientific Inc.
• Illumina, Inc
• Danaher, PerkinElmer Inc.
• Shimadzu Corporation
• Bruker
• QIAGEN
• Agilent Technologies, Inc.
• BGI

제12장 섹션

• 조사 방법
• 출판사 소개

ksm

영문 목차

영문목차

Global Multiomics Market is estimated to be valued at USD 2.47 Bn in 2025 and is expected to reach USD 6.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.47 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	15.40%	2032 Value Projection:	USD 6.73 Bn

Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biological data, multiomics facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as researchers realize the potential of integrated omics strategies to study health and disease. Advancements in experimental techniques, bioinformatics tools, and computing power are further accelerating the application of multiomics in biomedical research.

Market Dynamics:

The growing adoption of multiomics in personalized medicine, drug discovery, and development are some of the key factors expected to drive the growth of the multiomics market in the coming years. Multiomics approaches are increasingly being used in personalized medicine to develop effective, individualized treatments based on a patient's molecular profile. Pharmaceutical companies are also leveraging multiomics to identify novel drug targets and biomarkers and develop precision therapeutics. However, data integration and management challenges posed by large and complex multiomics datasets as well as lack of comprehensive analytical tools are some of the factors expected to restrain the market growth. Development of user-friendly data analysis solutions, standardization of data processing workflows, and establishment of omics data repositories could create lucrative opportunities for multiomics market players over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global multiomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global multiomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include BD, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global multiomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiomics market.

Detailed Segmentation:

• Global Multiomics Market, By Product & Service
  • Products
  • Instruments
  • Consumables
  • Software
  • Services
• Global Multiomics Market, By Type
  • Single-cell Multiomics
  • Bulk Multiomics
• Global Multiomics Market, By Platform
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms
• Global Multiomics Market, By Application
  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • AgriGenomics
  • Others (Environmental Monitoring, etc.)
• Global Multiomics Market, By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Research Organizations (CROs)
  • Others (Hospitals and Diagnostic Centers, etc.)
• Global Multiomics Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • BD
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher, PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Multiomics Market, By Product & Service
  • Global Multiomics Market, By Type
  • Global Multiomics Market, By Platform
  • Global Multiomics Market, By Application
  • Global Multiomics Market, By End User
  • Global Multiomics Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing usage of multiomics in personalized medicine
  • Growing investment in and funding of multiomics research
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service Offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Multiomics Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Multiomics Market, By Product & Service, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Instruments
• Consumables
• Software
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Multiomics Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single-cell Multiomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Bulk Multiomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Multiomics Market, By Platform, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Transcriptomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Proteomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Metabolomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Integrated Omics Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Multiomics Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Personalized Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• AgriGenomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others (Environmental Monitoring, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Multiomics Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Clinical Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others (Hospitals and Diagnostic Centers, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Multiomics Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

11. Competitive Landscape

• BD
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Illumina, Inc
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Danaher, PerkinElmer Inc.
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Shimadzu Corporation
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bruker
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies, Inc.
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BGI
  • Company Highlights
  • Product & Service Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us

관련자료